Department of Ophthalmology and Vision Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Division of Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
J Neurosci Res. 2019 Jan;97(1):29-44. doi: 10.1002/jnr.24213. Epub 2018 Jan 3.
The pediatric ocular cancer retinoblastoma is the only central nervous system (CNS) tumor readily observed without specialized equipment: it can be seen by, and in, the naked eye. This accessibility enables unique imaging modalities. Here, we review this cancer for a neuroscience audience, highlighting these clinical and research imaging options, including fundus imaging, optical coherence tomography, ultrasound, and magnetic resonance imaging. We also discuss the subtype of retinoblastoma driven by the MYCN oncogene more commonly associated with neuroblastoma, and consider trilateral retinoblastoma, in which an intracranial tumor arises along with ocular tumors in patients with germline RB1 gene mutations. Retinoblastoma research and clinical care can offer insights applicable to CNS malignancies, and also benefit from approaches developed elsewhere in the CNS.
小儿眼部癌症视网膜母细胞瘤是唯一一种无需特殊设备即可肉眼观察到的中枢神经系统 (CNS) 肿瘤:它可以通过肉眼观察到。这种可及性使独特的成像方式成为可能。在这里,我们为神经科学受众综述了这种癌症,重点介绍了这些临床和研究成像选择,包括眼底成像、光学相干断层扫描、超声和磁共振成像。我们还讨论了由 MYCN 癌基因驱动的更常与神经母细胞瘤相关的视网膜母细胞瘤亚型,并考虑了三侧性视网膜母细胞瘤,即具有种系 RB1 基因突变的患者中颅内肿瘤与眼部肿瘤同时发生。视网膜母细胞瘤的研究和临床护理可以提供适用于 CNS 恶性肿瘤的见解,也受益于 CNS 其他部位开发的方法。